Lucanthone inhibits autophagy and induces apoptosis in cancer cells through a p53-independent mechanism, mediated by an increase in cathepsin D, matrix metalloproteinase-1 (MMP1) and cytochrome P450 (CYP1A1) levels. This evidence concerns the gene TP53 and cancer.